1.
Thuy NTT, Duyen TTM, Chi NVL, Dung PT. Economic value of subcutaneous versus intravenous trastuzumab administration in the treatment of HER2-positive breast cancer: A systematic review. HIUJS [Internet]. 19 Tháng Chạp 2024 [cited 5 Tháng Chạp 2025];7:61-72. Available at: https://tapchikhoahochongbang.vn/js/article/view/894